Linked Life Data

15077073

Source:http://linkedlifedata.com/resource/pubmed/id/15077073

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2004-4-12
pubmed:abstractText
Staphylococcus aureus, the first or second most common pathogen isolated from patients, is capsulated; there are at least 12 capsular types, and types 5 and 8 comprise approximately 85% of blood. Types 5 and 8, composed of a trisaccharide repeat unit including a mannose uronic acid and 2 fucoses, are non-immunogenic. As protein conjugates, they induce opsonophagocytic antibodies that confer type-specific active and passive protection in mice.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1097-6744
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
147
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
593-8
pubmed:dateRevised
2006-2-27
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines.
pubmed:affiliation
National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA. robbinsjo@mail.nih.gov
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Clinical Trial, Phase III